Wall Street analysts expect Synchrony (SYF) to post quarterly earnings of $1.66 per share in its upcoming report, which indicates a year-over-year increase of 40.7%. Revenues are expected to be $4.55 billion, up 3.4% from the year-ago quarter. Over the last 30 days, there has been a downward revision of 6% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe. Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock. While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. In light of this perspective, let's dive into the average estimates of certain Synchrony metrics that are commonly tracked and forecasted by Wall Street analysts. The combined assessment of analysts suggests that 'Efficiency Ratio' will likely reach 32.4%. The estimate compares to the year-ago value of 25.1%. According to the collective judgment of analysts, 'Net interest margin' should come in at 14.8%. The estimate is in contrast to the year-ago figure of 14.6%. Analysts predict that the 'Total Average Loan receivables, including held for sale' will reach $102.79 billion. Compared to the current estimate, the company reported $100.96 billion in the same quarter of the previous year. The consensus among analysts is that 'Net charge-offs as of average loan receivables' will reach 6.6%. The estimate is in contrast to the year-ago figure of 6.3%. The collective assessment of analysts points to an estimated 'Total Purchase Volume' of $42.35 billion. The estimate is in contrast to the year-ago figure of $42.39 billion. The average prediction of analysts places 'Total Period-end loan receivables' at $102.39 billion. The estimate is in contrast to the year-ago figure of $101.73 billion. The consensus estimate for 'Total interest-earning assets - Average Balance' stands at $125.95 billion. Compared to the current estimate, the company reported $121.79 billion in the same quarter of the previous year. Story Continues Analysts expect 'Platform Analysis - Digital - Period-end loan receivables' to come in at $27.95 billion. Compared to the present estimate, the company reported $27.73 billion in the same quarter last year. Analysts' assessment points toward 'Platform Analysis - Home & Auto - Average loan receivables, including held for sale' reaching $32.33 billion. Compared to the current estimate, the company reported $31.87 billion in the same quarter of the previous year. It is projected by analysts that the 'Platform Analysis - Diversified & Value - Purchase volume' will reach $14.24 billion. The estimate compares to the year-ago value of $14.02 billion. Analysts forecast 'Platform Analysis - Diversified & Value - Period-end loan receivables' to reach $19.69 billion. The estimate is in contrast to the year-ago figure of $19.56 billion. Based on the collective assessment of analysts, 'Platform Analysis - Diversified & Value - Average loan receivables, including held for sale' should arrive at $19.75 billion. The estimate compares to the year-ago value of $19.59 billion. View all Key Company Metrics for Synchrony here>>> Over the past month, Synchrony shares have recorded returns of -10.4% versus the Zacks S&P 500 composite's -4.2% change. Based on its Zacks Rank #3 (Hold), SYF will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Synchrony Financial (SYF):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
What Analyst Projections for Key Metrics Reveal About Synchrony (SYF) Q1 Earnings
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...